Skip to main content
. 2021 Jan 29;22(3):1377. doi: 10.3390/ijms22031377

Figure 3.

Figure 3

Characteristics of intestinal injury in FcgRIIb-/- lupus mice and wild-type (FcgRIIb+/+) mice after the administration of indomethacin (NSAIDs) or phosphate buffer solution (PBS) control as determined by intestinal histopathological scores (AD), immune deposition (E–H), and intestinal cytokines (I–L) (n = 6–8/group).